DD139848A5 - Verfahren zur herstellung neuer 3-pyrazol-1-yl-pyridazin-derivate - Google Patents

Verfahren zur herstellung neuer 3-pyrazol-1-yl-pyridazin-derivate Download PDF

Info

Publication number
DD139848A5
DD139848A5 DD78206732A DD20673278A DD139848A5 DD 139848 A5 DD139848 A5 DD 139848A5 DD 78206732 A DD78206732 A DD 78206732A DD 20673278 A DD20673278 A DD 20673278A DD 139848 A5 DD139848 A5 DD 139848A5
Authority
DD
German Democratic Republic
Prior art keywords
group
general formula
meaning
carbon atoms
same
Prior art date
Application number
DD78206732A
Other languages
German (de)
English (en)
Inventor
Geza Szilagyi
Endre Kasztreiner
Laszlo Tardos
Edit Kosa
Laszlo Jaszlits
Gyoergy Cseh
Ilona Kovacs
Pal Olnay
Sandor Elek
Istvan Elekes
Istvan Polgari
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of DD139848A5 publication Critical patent/DD139848A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD78206732A 1977-10-25 1978-07-14 Verfahren zur herstellung neuer 3-pyrazol-1-yl-pyridazin-derivate DD139848A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77GO1381A HU176100B (en) 1977-10-25 1977-10-25 Process for preparing new 3-/1-pyrazolyl/-pyridazine derivatives

Publications (1)

Publication Number Publication Date
DD139848A5 true DD139848A5 (de) 1980-01-23

Family

ID=10996838

Family Applications (1)

Application Number Title Priority Date Filing Date
DD78206732A DD139848A5 (de) 1977-10-25 1978-07-14 Verfahren zur herstellung neuer 3-pyrazol-1-yl-pyridazin-derivate

Country Status (24)

Country Link
US (1) US4224325A (cs)
JP (1) JPS5461187A (cs)
AT (1) AT359076B (cs)
AU (1) AU525814B2 (cs)
BE (1) BE868987A (cs)
CA (1) CA1090337A (cs)
CH (1) CH637951A5 (cs)
CS (1) CS217964B2 (cs)
DD (1) DD139848A5 (cs)
DE (1) DE2831072A1 (cs)
DK (1) DK317678A (cs)
ES (1) ES471779A1 (cs)
FI (1) FI63397C (cs)
FR (1) FR2407211A1 (cs)
GB (1) GB2007644B (cs)
HU (1) HU176100B (cs)
IL (1) IL55120A (cs)
IT (1) IT1097156B (cs)
NL (1) NL7807572A (cs)
NO (1) NO149354C (cs)
PL (2) PL115063B1 (cs)
SE (1) SE437988B (cs)
SU (3) SU847920A3 (cs)
YU (1) YU169878A (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302456A (en) * 1977-04-13 1981-11-24 The Upjohn Company Process for therapeutic treatment
US4302457A (en) * 1977-04-13 1981-11-24 The Upjohn Company Process for therapeutic treatment
DE2935359A1 (de) * 1979-09-01 1981-03-26 Basf Ag, 67063 Ludwigshafen 6-imidazolyl-3-hydrazino-pyridazine
US4304775A (en) * 1979-12-13 1981-12-08 Sterling Drug Inc. 3-Hydrazino-6-(pyridinyl) pyridazines and cardiotonic use thereof
US4503056A (en) * 1982-03-02 1985-03-05 Abbott Laboratories 1-(Pyridazinyl)pyrazoline derivatives
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1220428B (de) 1960-03-25 1966-07-07 Takeda Pharmaceutical Verfahren zur Herstellung von 2-Pyrazolyl-(1')-pyrimidinderivaten und deren Salzen
JPS5831347B2 (ja) * 1975-09-05 1983-07-05 中外製薬株式会社 ピラゾリルピリダジンユウドウタイノ セイホウ
HU175471B (hu) * 1977-06-13 1980-08-28 Gyogyszerkutato Intezet Sposob poluchenija novykh proizvodnykh 3-skobka-1-pirazolil-skobka zakryta-piridazina

Also Published As

Publication number Publication date
NO149354B (no) 1983-12-27
AT359076B (de) 1980-10-27
JPS5527063B2 (cs) 1980-07-17
FI782237A7 (fi) 1979-04-26
SU845786A3 (ru) 1981-07-07
SE7807822L (sv) 1979-04-26
SE437988B (sv) 1985-03-25
FR2407211A1 (fr) 1979-05-25
DE2831072A1 (de) 1979-05-10
NL7807572A (nl) 1979-04-27
PL118799B1 (en) 1981-10-31
DK317678A (da) 1979-04-26
CA1090337A (en) 1980-11-25
IL55120A (en) 1982-05-31
AU525814B2 (en) 1982-12-02
IT7825681A0 (it) 1978-07-14
NO149354C (no) 1984-04-04
FR2407211B1 (cs) 1982-09-03
ATA509278A (de) 1980-03-15
SU847920A3 (ru) 1981-07-15
ES471779A1 (es) 1979-10-01
CS217964B2 (en) 1983-02-25
AU3799778A (en) 1980-01-17
SU856385A3 (ru) 1981-08-15
HU176100B (en) 1980-12-28
GB2007644B (en) 1982-03-10
YU169878A (en) 1983-01-21
BE868987A (fr) 1979-01-15
JPS5461187A (en) 1979-05-17
PL115063B1 (en) 1981-03-31
US4224325A (en) 1980-09-23
CH637951A5 (de) 1983-08-31
PL208409A1 (cs) 1980-02-25
FI63397B (fi) 1983-02-28
NO782446L (no) 1979-04-26
IL55120A0 (en) 1978-09-29
FI63397C (fi) 1983-06-10
GB2007644A (en) 1979-05-23
IT1097156B (it) 1985-08-26
PL218031A1 (cs) 1980-07-14

Similar Documents

Publication Publication Date Title
EP1418176B1 (de) Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
EP1040101B1 (de) Substituierte 2-aryl-4-amino-chinazoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP1339714B1 (de) Neue sulfonamid-substituierte pyrazolopyridinderivate
DE19744027A1 (de) Substituierte Pyrazolo[3,4-b]pyridine, ihre Herstellung und Verwendung in Arzneimitteln
DD140043A5 (de) Verfahren zur herstellung neuer 3-(pyrazol-1-yl)-pyridazin-derivate
EP0090978B1 (de) Imidazolylphenyl-tetrahydropyridazine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
EP0271040A2 (de) Neue Pyrrolobenzimidazole, Verfahren zu ihrer Herstellung, sowie Arzneimittel
EP0327800A2 (de) 6-Phenyldihydro-3(2H)-pyridazinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE68925270T2 (de) Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidinderivate und diese enthaltende Arzneimittel
NZ207914A (en) Indeno-pyridazinones and pharmaceutical compositions
DD139848A5 (de) Verfahren zur herstellung neuer 3-pyrazol-1-yl-pyridazin-derivate
EP0175187B1 (de) Neue, eine Imidazol-gruppe enthaltende 3,4-Dihydro-2(1H)-Pyridone und 2(1H)-Pyridone, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0003144A2 (de) 4-Pyridon-3-carbonsäurederivate, diese enthaltende pharmazeutische Präparate und deren Herstellung sowie deren Verwendung
DE1620016C3 (de) 3-{Piperazinoalkyl)-pyrazole und Verfahren zu ihrer Herstellung
DD157614A5 (de) Verfahren zur herstellung von pyrimidyl-chinazolinen
DE2841644C2 (cs)
DE2708187A1 (de) Neue pyrido-pyridazin-one
DE2825861C2 (cs)
EP0680954A2 (de) Verfahren zur Herstellung von 1-(Het)aryl-3-hydroxy-pyrazolen
DE2935359A1 (de) 6-imidazolyl-3-hydrazino-pyridazine
DE3432985C2 (cs)
DE3241827T1 (de) Neue s-Triazolo[1,5-a]pyrimidin-Derivate
WO1990001479A1 (de) 4,5-dihydro-3(2h)-pyridazinone, verfarhren zu ihrer herstellung und ihre verwendung
CH644125A5 (de) Benzo-as-triazin-derivate und verfahren zur herstellung derselben.
DE69500156T2 (de) Imidazopyridin-Derivate und Verfahren zu ihrer Herstellung